BPMX BioPharmX Corporation

SAN JOSE, Calif., March 18, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced presentations at multiple upcoming investor conferences.

President and CEO Dr. David S. Tierney will present the latest company overview at:

• The 31^st Annual ROTH Conference on Monday, March 18 at 8:30am Pacific Time in Laguna Niguel, CA.
• The Oppenheimer 29^th Annual Healthcare Conference on Wednesday, March 20, 2019 at 1:00pm Eastern Time in New York, NY.

About BioPharmX® Corporation
BioPharmX Corporation (NYSE American: BPMX) is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX™ Topical Delivery System for dermatology indications. To learn more about BioPharmX, visit www.BioPharmX.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/biopharmx-to-participate-in-the-31st-annual-roth-conference-and-the-oppenheimer-29th-annual-healthcare-conference-300813694.html

SOURCE BioPharmX Corporation